GREENLAND MINES LTD Earnings Per Share (Basic)
GREENLAND MINES LTD (GRML) reported Earnings Per Share (Basic) of -$0.03 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-17
- GREENLAND MINES LTD earnings per share, basic for the quarter ending 2026-06-30 was -$0.03.
- GREENLAND MINES LTD earnings per share, basic for the quarter ending 2026-03-31 was -$0.15.
- GREENLAND MINES LTD earnings per share, basic for the quarter ending 2025-12-31 was -$0.02.
- GREENLAND MINES LTD earnings per share, basic for the quarter ending 2025-09-30 was -$0.05.
- GREENLAND MINES LTD earnings per share, basic for fiscal 2025 was -$0.22.
- GREENLAND MINES LTD earnings per share, basic for fiscal 2024 was -$0.32.
- GREENLAND MINES LTD earnings per share, basic for fiscal 2023 was -$0.05.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.03 10-Q · filed 2026-08-17 | -$0.16 10-Q · filed 2026-08-17 | -$0.19 derived: net income ÷ weighted average shares · filed 2026-08-17 | -$0.25 derived: net income ÷ weighted average shares · filed 2026-08-17 |
| 2026-03-31 | -$0.15 10-Q/A · filed 2026-08-14 | -$0.18 derived: net income ÷ weighted average shares · filed 2026-08-17 | -$0.24 derived: net income ÷ weighted average shares · filed 2026-08-17 | -$0.34 derived: net income ÷ weighted average shares · filed 2026-08-17 |
| 2025-12-31 | -$0.02 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$0.06 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$0.15 derived: net income ÷ weighted average shares · filed 2026-08-17 | -$0.22 10-K/A · filed 2026-08-14 |
| 2025-09-30 | -$0.05 10-Q · filed 2025-11-13 | -$0.15 derived: net income ÷ weighted average shares · filed 2026-08-17 | -$0.23 10-Q · filed 2025-11-13 | -$0.30 derived: net income ÷ weighted average shares · filed 2026-08-17 |
| 2025-06-30 | -$0.12 10-Q · filed 2026-08-17 | -$0.21 10-Q · filed 2026-08-17 | -$0.28 derived: net income ÷ weighted average shares · filed 2026-08-17 | -$0.43 derived: net income ÷ weighted average shares · filed 2026-08-17 |
| 2025-03-31 | -$0.08 10-Q/A · filed 2026-08-14 | -$0.16 derived: net income ÷ weighted average shares · filed 2026-08-17 | -$0.30 derived: net income ÷ weighted average shares · filed 2026-08-17 | -$0.35 derived: net income ÷ weighted average shares · filed 2026-08-17 |
| 2024-12-31 | -$0.08 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$0.23 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$0.28 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$0.32 10-K/A · filed 2026-08-14 |
| 2024-09-30 | -$0.18 10-Q · filed 2025-11-13 | -$0.21 derived: net income ÷ weighted average shares · filed 2025-11-13 | -$0.25 10-Q · filed 2025-11-13 | -$0.27 derived: net income ÷ weighted average shares · filed 2025-11-13 |
| 2024-06-30 | -$0.03 10-Q · filed 2025-08-18 | -$0.07 10-Q · filed 2025-08-18 | -$0.08 derived: net income ÷ weighted average shares · filed 2025-11-13 | -$0.09 derived: net income ÷ weighted average shares · filed 2025-11-13 |
| 2024-03-31 | -$0.04 10-Q · filed 2025-05-15 | -$0.05 derived: net income ÷ weighted average shares · filed 2025-11-13 | -$0.06 derived: net income ÷ weighted average shares · filed 2025-11-13 | -$0.08 derived: net income ÷ weighted average shares · filed 2025-11-13 |
| 2023-12-31 | -$0.01 derived: net income ÷ weighted average shares · filed 2025-03-31 | -$0.02 derived: net income ÷ weighted average shares · filed 2025-03-31 | -$0.04 derived: net income ÷ weighted average shares · filed 2025-03-31 | -$0.05 10-K · filed 2025-03-31 |
| 2023-09-30 | -$0.01 10-Q · filed 2024-11-19 | -$0.03 derived: net income ÷ weighted average shares · filed 2024-11-19 | -$0.04 10-Q · filed 2024-11-19 | |
| 2023-06-30 | -$0.02 10-Q · filed 2024-08-19 | -$0.03 10-Q · filed 2024-08-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |